SWHR convened thought leaders for a public panel discussion on migraine and women’s health that included patients, practitioners, and the employer perspective.
BlogSWHR hired of Dr. Irene Aninye as SWHR’s new Director of Science Programs.
BlogThis guest blog by Amita Sehgal, PhD from University of Pennsylvania and SWHR Interdisciplinary Network on Sleep Member and Paula Haynes, PhD from University of Pennsylvania explores circadian disorders.
EventSWHR is deeply concerned and discouraged to see that the Administration has deprioritized research and development in the 2018 budget through substantial decreases for critical federal agencies, expressed Dr. Amy M. Miller, SWHR president and CEO.
BlogSWHR congratulates the Congress and the President for approving the Food and Drug Administration (FDA) Reauthorization Act of 2017. By providing significant funding and important improvements to FDA’s medical products review and approval process, this law will enable timely access to safe and effective medical innovations to millions of patients who need them.
BlogSWHR announced the election to its Board of Directors of Jenelle S. Krishnamoorthy, PhD, associate vice president for global policy, communications and population health at Merck.
BlogTo draw attention to the need for research and policy changes to address migraine burden, advocacy group Research!America hosted a congressional briefing on Oct. 3 that included SWHR President and CEO Amy M. Miller.
BlogMaternal mortality rates in the United States are higher than anywhere else in the developed world, and the majority of the estimated 700 pregnancy-related deaths each year are preventable.
BlogSWHR CEO Amy M. Miller announces that she is leaving in 2020 and SWHR begins search for new leader.